Never miss a story

Get subscribed to our newsletter


×
Nerve Cell Cancer Survivors, At Higher Risk Of Developing Depression, Pixabay

Researchers have found that patients who suffered from pediatric neuroblastoma — a childhood cancer of nerve cells — may have a higher risk of developing long term psychological difficulties, including depression and attention deficit disorders.

“These findings are novel because this is the first large study that could look at how neuroblastoma patients are doing in terms of psychological and educational outcomes,” said one of the researchers Nina Kadan-Lottick from Yale University School of Medicine in the US.


“Our hope is that these findings will help inform strategies for early screening and intervention to identify those survivors at highest risk for developing psychological and educational impairment later on in life,” Lottick explained.

The study, published in the journal Cancer, analysed data from 859 children who had been diagnosed with neuroblastoma at least five years earlier and were under 18 years old. The data were compared with the additional data from 872 siblings of these patients.


A nerve, Representational image, flickr

The results showed that neuroblastoma survivors had 19 per cent increased prevalence of impairment in the domains of anxiety or depression as opposed to 14 per cent among the siblings.

The team also found that 19 per cent increased risk of headstrong behaviour among the patients as opposed to 13 per cent among the sibling group.

The patients group had 21 per cent higher prevalence of attention deficit disorders and 16 per cent higher risk of antisocial behaviour compared to 13 per cent and 12 per cent risk respectively in the sibling group.

Treatment advances in recent years have prolonged survival for many children diagnosed with neuroblastoma, but their young age at diagnosis and the specific therapies they receive can make them vulnerable to health problems as their central nervous system develops, the study said.


Mental patient, representational image, flickr

Also read: Finally the cause of depression among diabetes patients decoded

“The goal is not simply to get our patients to be cancer-free but also to optimise their mental, emotional, and social functioning as they move into adolescence and adulthood,” Lottick said. (IANS)


Popular

Photo by Alexander Shatov on Unsplash

Twitter has confirmed that its algorithms amplify right-leaning political content.

By Nikhila Natarajan

In a continuing study on the effects of machine learning (ML) on public conversation, Twitter has confirmed that its algorithms amplify right-leaning political content. "In six out of seven countries - all but Germany - tweets posted by accounts from the political right receive more algorithmic amplification than the political left when studied as a group," Twitter blogged.

"Right-leaning news outlets, as defined by the independent organisations, see greater algorithmic amplification on Twitter compared to left-leaning news outlets." Since 2016, Twitter users are able to choose between viewing algorithmically ordered tweets first in their home timeline or viewing the most recent tweets in reverse chronological order.

"An algorithmic home timeline displays a stream of tweets from accounts we have chosen to follow on Twitter, as well as recommendations of other content Twitter thinks we might be interested in based on accounts we interact with frequently, tweets we engage with, and more. "As a result, what we see on our timeline is a function of how we interact with Twitter's algorithmic system, as well as how the system is designed."

The new research is based on tweets of elected officials of House of Commons members in Canada, the French National Assembly, the German Bundestag, House of Representatives in Japan, Congress of Deputies of Spain, House of Commons in the UK, and official and personal accounts of House of Representatives and Senate members in the US, as well as news outlets, from April 1 to August 15, 2020.

gold Apple iPhone 6s displaying Twitter logo Tweets about political content from elected officials, regardless of party or whether the party is in power, do see algorithmic amplification when compared to political content on the reverse chronological timeline. | Photo by Sara Kurfeß on Unsplash

Keep Reading Show less
Flickr

Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal.

Even as India celebrates reaching a milestone of 100 crore Covid vaccine doses, Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal. In a video shared on his Facebook and Twitter page, Bansal hailed Sonu Kumar as a "citizen celebrity".

Bansal said that Kumar not only helped "just co-workers and family but complete strangers too. With patience, empathy and uncanny jugaad". He added that Kumar joined him "many moons ago" and completed his open school from a parking lot.

"Education has helped this wonderful man enable others to get India back on track. Bravo! The CoWin portal on Thursday mentioned that a total of 100 crore vaccine doses has been administered so far to the eligible population under the vaccination drive in India, nine months after the nationwide inoculation programme was started to protect the people against Covid-19.

"It's a cause of significant celebration and happiness," Bansal said in the video. He said that while people just help a few around them, Kumar "bridged the digital gap" for 64 people, who were finding it difficult to register themselves online on the vaccine portal. Kumar said he doesn't feel that he has contributed much towards the 100 crore vaccine dose count. "I have been able to help only 64 people, if I was able to help more I would have been happier." (IANS/ MBI)


Keep Reading Show less
VOA

A health worker counts antiretroviral drug tablets for a patient at The AIDS Support Organization (TASO) in the capital Kampala, Uganda, July 12, 2012.

KAMPALA, UGANDA — Uganda has kickstarted a trial for the injectable HIV drugs cabotegravir and rilpivirine. Researchers and those living with HIV say the trial will likely end pill fatigue, fight stigma, improve adherence and ensure patients get the right dosage.

The two drugs have been in use as tablets. The World Health Organization last year licensed their use as injectables.

Keep reading... Show less